Literature DB >> 23224054

Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.

Masahiro Takeyama1, Hironao Wakabayashi, Philip J Fay.   

Abstract

Although factor (F) VIIIa is inactivated by activated protein C (APC) through cleavages in the FVIII heavy chain-derived A1 (Arg(336)) and A2 subunits (Arg(562), the FVIII light chain (LC) contributes to catalysis by binding the enzyme. ELISA-based binding assays showed that FVIII and FVIII LC bound to immobilised active site-modified APC (DEGR-APC) (apparent K(d) ~270 nM and 1.0 μM, respectively). Fluid-phase binding studies using fluorescence indicated an estimated K(d) of ~590 nM for acrylodan-labelled LC binding to DEGR-APC. Furthermore, FVIII LC effectively competed with FVIIIa in blocking APC-catalysed cleavage at Arg(336) (K(i) = 709 nM). A binding site previously identified near the C-terminal end of the A3 domain (residues 2007-2016) of FVIII LC was subjected to Ala-scanning mutagenesis. FXa generation assays and western and dot blotting were employed to assess the contribution of these residues to FVIIIa interactions with APC. Virtually all variants tested showed reductions in the rates of APC-catalysed inactivation of the cofactor and cleavage at the primary inactivation site (Arg(336)), with maximal reductions in inactivation rates (~3-fold relative to WT) and cleavage rates (~3 to ~9-fold relative to WT) observed for the Met2010Ala, Ser2011Ala, and Leu2013Ala variants. Titration of FVIIIa substrate concentration monitoring cleavage by a dot blot assay indicated that these variants also showed ~3-fold increases relative to WT while a double mutant (Met2010Ala/Ser2011Ala) showed a >4-fold increase in K(m). These results show a contribution of a number of residues within the 2007-2016 sequence, and in particular residues Met2010, Ser2011, and Leu2013 to an APC-interactive site.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224054      PMCID: PMC3665284          DOI: 10.1160/TH12-08-0561

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  31 in total

Review 1.  Activation of factor VIII and mechanisms of cofactor action.

Authors:  Philip J Fay
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

2.  Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.

Authors:  L M O'Brien; M Mastri; P J Fay
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

3.  Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

Authors:  L O Andersson; N Forsman; K Huang; K Larsen; A Lundin; B Pavlu; H Sandberg; K Sewerin; J Smart
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

5.  The size of human factor VIII heterodimers and the effects produced by thrombin.

Authors:  P J Fay; M T Anderson; S I Chavin; V J Marder
Journal:  Biochim Biophys Acta       Date:  1986-06-23

6.  The binding of activated protein C to factors V and Va.

Authors:  S Krishnaswamy; E B Williams; K G Mann
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

7.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Biochemistry       Date:  2012-01-17       Impact factor: 3.162

9.  Exosite-dependent regulation of factor VIIIa by activated protein C.

Authors:  Chandrashekhara Manithody; Philip J Fay; Alireza R Rezaie
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

10.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.

Authors:  L T Mimms; G Zampighi; Y Nozaki; C Tanford; J A Reynolds
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more
  3 in total

1.  Long-term correction of hemorrhagic diathesis in hemophilia A mice by an AAV-delivered hybrid FVIII composed of the human heavy chain and the rat light chain.

Authors:  Jianhua Mao; Yun Wang; Wei Zhang; Yan Shen; Guowei Zhang; Wenda Xi; Qiang Wang; Zheng Ruan; Jin Wang; Xiaodong Xi
Journal:  Front Med       Date:  2022-01-17       Impact factor: 9.927

2.  Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

3.  The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Authors:  Magdalena Gierula; Isabelle I Salles-Crawley; Salvatore Santamaria; Adrienn Teraz-Orosz; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  J Thromb Haemost       Date:  2019-08-09       Impact factor: 5.824

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.